COVID-19 Vaccine Optimism, Business Leaders' ...

Cramer says he likes this chipmaker at its current level. Become an Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks every day as they talk candidly about the market’s biggest headlines, analyst calls and holdings in the Charitable Trust – and see up c ...  Show more

Sequoia Capital Partner Shaun Maguire discusses investment opportunity in Israel and how the economy has evolved there. Then, we break down a new congressional report on Webull's China ties that has the stock tumbling today. Plus, T. Rowe Price Portfolio Manager Tony Wang discuss ...  Show more

Pfizer announces encouraging results from its COVID-19 vaccine. Disney gives investors 73 million reasons for optimism. Beyond Meat reports a surprising loss. Lyft reports a surprising increase in revenue. And DoorDash prepares for an IPO. Motley Fool analysts Ron Gross and Jason ...  Show more

It has been a busy few days for the United States as the pandemic-related news has been fast and furious. Pfizer reported better-than-expected profits and a lot of its revenue has come from the COVID-19 vaccine. Maxx Chatsko joins Dan Kline to talk about that, President Joe Bi ...

Michael Dowling, CEO at Northwell Health, discusses the U.S. government expected to recommend booster shots eight months after people get their second vaccine dose. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Deals Reporter Scott Deveau talk about how the SPAC boo ...  Show more

All three averages slipped and Jim Cramer is helping investors navigate market volatility in this holiday-shortened week. First, On opened its newest location in Williamsburg last week and Cramer is sitting down with co-CEO Martin Hoffmann at the Brooklyn flagship to learn mor ...